Vanguard Capital Management 13D/13G Filings for Rani Therapeutics Holdings, Inc. (RANI)

Vanguard Capital Management 13D and 13G filings for Rani Therapeutics Holdings, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-07-31
10:42 am
Sale
2026-06-3013GRANI THERAPEUTICS HLDGS INC CO
RANI
Vanguard Capital Management5,052,862
4.490%
-56,506decrease
(-1.11%)
Filing
2026-04-30
12:57 pm
Purchase
2026-03-3113GRANI THERAPEUTICS HLDGS INC CO
RANI
Vanguard Capital Management5,109,368
5.120%
5,109,368increase
(New Position)
Filing